アスペルギルスと宿主-病原菌の相互作用:治療に関連する側面に焦点を当てた
Romain Manchon1, Simon Feys2, Martin Hoenigl3
1Institut Pasteur, Université Paris Cité, Immunologie des Infections Fongiques, Paris, France; Infectious Diseases Department, Necker-Enfants Malades Hospital, Université Paris Cité, AP-HP, Paris, France.
まとめ
侵入性アスペルギロシス (IA) の宿主免疫を理解することは,新しい治療法の開発の鍵です. パーソナライズされた免疫療法は この深刻な真菌感染症に直面している 免疫機能低下した患者の 治療結果を改善する希望を提供します
科学分野:
- 免疫学
- 感染症
- 薬剤療法
背景:
- 侵襲性アスペルギロシス (IA) は,特に集中治療室での免疫低下患者の死亡の主な原因です.
- 最適でない結果と抗真菌抵抗は,宿主の免疫メカニズムを標的とした新しい補助療法を必要とします.
- IAの病原化には,アスペルギルス種,主にアスペルギルス・フミガトゥスに対する複雑で異質な免疫反応が含まれます.
研究 の 目的:
- ホストとアスペルギルスとの相互作用における免疫成分の役割を見直す.
- 免疫を標的とする新しい治療法を 探求するためです
- パーソナライズされた免疫療法の可能性を 強調するためです
主な方法:
- 最近の臨床前および臨床研究の包括的な文献分析.
- IAの免疫病原性に関する現在の理解をまとめます.
- 抗真菌治療に付随する免疫ベースの治療法の評価
主要な成果:
- ホストの免疫反応は複雑で異質で,均一な治療を複雑にする.
- 免疫ベースの治療法は従来の抗真菌薬の補助薬として有望である.
- 免疫プロファイルに合わせた パーソナライズされたアプローチが生まれています
結論:
- IAにおける宿主免疫を理解することは,正確で個別化された治療戦略の開発に不可欠です.
- 標的型免疫療法は,IAやその他の機会性感染症の管理における有望な境界線を表しています.
- これらの洞察を臨床応用に 応用するにはさらなる研究が必要です
関連する概念動画
01:28Fungal Phylum Ascomycota
138
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
138
01:28Fungal Phylum Microsporidia
110
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
110
01:20Asthma: Pathogenesis and Management
573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573
01:29Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
01:28Pulmonary Tuberculosis V
236
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
236
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.5K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.5K